Rubedo Life Sciences
Extending Health Span and Reverting Age-Related Diseases.
Rubedo Life Sciences is an anti-aging company based in the Silicon Valley, California. Rubedo mission is to extend health-span by targeting cell in the body in an accurate and safe way. We aim to remove from the body "bad cells" that drive agin (such as the pro-inflammatory senescent cells), and to improve functions of "good cells (such as stem cells). Rubedo is developing treatments for aged-related diseases such as Alzheimer’s, Cancer, Diabetes, or Arthritis. The company is founded and driven by leaders in aging, regenerative medicine, senescence, combinatorial and medicinal chemistry from top academics (such as Stanford, Berkley and Cambridge UK) and top life sciences companies (such as Affymax, Xenoport, Verily).
Visit website: https://www.rubedolife.com/
People at Rubedo Life Sciences
Rubedo Life Sciences News
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few yearsRead more...
Rubedo's lead compound targets inflammatory skin disease with selective senolytic approach
Business Wire - 20-Mar-2023
Rubedo is planning first-in-human studies in multiple skin indications driven by chronic inflammationRead more...
Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit
Lifespan.io (LEAF) - 20-Jan-2023
Another reminder of the amount of research, with multiple approaches, about to go into clinical trialsRead more...
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...
Rubedo to first work on lung diseases
Longevity Technology - 20-Jan-2021
Their work will be critical amidst the COVID-19 pandemic - to move into clinical trials soonRead more...
LMC provides background and success outlook on 14 leading senolytic companies
Longevity Marketcap - 15-Dec-2020
Comprehensive review of companies' clinical and financial state of playRead more...